The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change+5.3% to $410.00
Predicted High$412.00at 5 months
Predicted Low$394.50in 2 weeks
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Jul 25, 2026 11:55 am
Bull
HUM trends higher to
$410.00
(+5.3% from $389.32)
by Jan 2027.
ride-then-fade
ThesisHUM has ripped 46% over six months with a low-beta defensive profile and consistent EPS beats, but with no fair-value anchor and a bear scenario far above spot, the tape likely continues drifting higher on momentum and pre-earnings beat chatter, with mild consolidation as the MA regulatory narrative periodically caps enthusiasm.
Invalidated ifA break below $360 on heavy volume or an adverse MA regulatory headline would falsify the continued grind higher.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $389.32 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Jul 25, 2026
—
$389.32at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 8, 2026
$356.03–$422.61typical range · internal point $394.50
—
±8.6%
7/10
Momentum and low beta sustain modest drift up
What actually happened:
closed $385.02
on Aug 7, 2026 = -1.1% vs the call
(predicted +1.3%)
· direction HIT
(called flat, was flat)
· off by 2.4 pp
· accuracy 9/10
· typical range ±8.6%:
inside the band
· S&P +4.7%
over the same window — beat it
1 month
Aug 25, 2026
$341.08–$437.56typical range · internal point $399.00
—
±12.4%
6/10
Pre-earnings beat chatter supports continued bid
2 months
Sep 25, 2026
$405.00
—
+4.0%
5/10
Q3 print likely another beat given 3-of-3 streak
3 months
Oct 25, 2026
$402.00
—
+3.3%
4/10
Post-earnings digestion, MA overhang caps upside
4 months
Nov 25, 2026
$408.00
—
+4.8%
4/10
Defensive bid returns in choppy tape
5 months
Dec 25, 2026
$412.00
—
+5.8%
3/10
Year-end positioning favors quality defensives
6 months
Jan 25, 2027
$410.00
—
+5.3%
3/10
Consolidation as regulatory narrative resurfaces
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$0.00
(+0.0%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.